Warning: The NCBI web site requires JavaScript to function. more...
APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication.
Li L, Liang D, Li JY, Zhao RY.
Retrovirology. 2008 Aug 4;5:72.
Related citations
Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.
Mehle A, Strack B, Ancuta P, Zhang C, McPike M, Gabuzda D.
J Biol Chem. 2004 Feb 27;279(9):7792-8. Epub 2003 Dec 13.
Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
Liu B, Yu X, Luo K, Yu Y, Yu XF.
J Virol. 2004 Feb;78(4):2072-81.
[Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
Fan B, Cen S, Jiang JD.
Yao Xue Xue Bao. 2008 Jul;43(7):678-82. Review. Chinese.
Function analysis of sequences in human APOBEC3G involved in Vif-mediated degradation.
Zhang L, Saadatmand J, Li X, Guo F, Niu M, Jiang J, Kleiman L, Cen S.
Virology. 2008 Jan 5;370(1):113-21. Epub 2007 Oct 4.
Heat shock protein 70 inhibits HIV-1 Vif-mediated ubiquitination and degradation of APOBEC3G.
Sugiyama R, Nishitsuji H, Furukawa A, Katahira M, Habu Y, Takeuchi H, Ryo A, Takaku H.
J Biol Chem. 2011 Mar 25;286(12):10051-7. Epub 2011 Jan 12.
Inhibition of HIV-1 infection and replication by enhancing viral incorporation of innate anti-HIV-1 protein A3G: a non-pathogenic Nef mutant-based anti-HIV strategy.
Green LA, Liu Y, He JJ.
J Biol Chem. 2009 May 15;284(20):13363-72. Epub 2009 Mar 26.
N-terminal hemagglutinin tag renders lysine-deficient APOBEC3G resistant to HIV-1 Vif-induced degradation by reduced polyubiquitination.
Wang Y, Shao Q, Yu X, Kong W, Hildreth JE, Liu B.
J Virol. 2011 May;85(9):4510-9. Epub 2011 Feb 23.
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.
Doehle BP, Schäfer A, Cullen BR.
Virology. 2005 Sep 1;339(2):281-8.
Polyubiquitination of APOBEC3G is essential for its degradation by HIV-1 Vif.
Shao Q, Wang Y, Hildreth JE, Liu B.
J Virol. 2010 May;84(9):4840-4. Epub 2010 Feb 10.
A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
Xu H, Svarovskaia ES, Barr R, Zhang Y, Khan MA, Strebel K, Pathak VK.
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5652-7. Epub 2004 Mar 30.
Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.
Ao Z, Yu Z, Wang L, Zheng Y, Yao X.
PLoS One. 2008 Apr 16;3(4):e1995.
The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G.
Miller JH, Presnyak V, Smith HC.
Retrovirology. 2007 Nov 24;4:81.
The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.
Kao S, Khan MA, Miyagi E, Plishka R, Buckler-White A, Strebel K.
J Virol. 2003 Nov;77(21):11398-407.
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.
Sheehy AM, Gaddis NC, Malim MH.
Nat Med. 2003 Nov;9(11):1404-7. Epub 2003 Oct 5.
HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation.
Santa-Marta M, da Silva FA, Fonseca AM, Goncalves J.
J Biol Chem. 2005 Mar 11;280(10):8765-75. Epub 2004 Dec 20.
The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation.
Donahue JP, Vetter ML, Mukhtar NA, D'Aquila RT.
Virology. 2008 Jul 20;377(1):49-53. Epub 2008 May 21.
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.
Stopak K, de Noronha C, Yonemoto W, Greene WC.
Mol Cell. 2003 Sep;12(3):591-601.
Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif.
Kao S, Goila-Gaur R, Miyagi E, Khan MA, Opi S, Takeuchi H, Strebel K.
Virology. 2007 Dec 20;369(2):329-39. Epub 2007 Sep 6.
Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.
Zhang W, Chen G, Niewiadomska AM, Xu R, Yu XF.
PLoS One. 2008;3(12):e3963. Epub 2008 Dec 17.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on